VTVT — vTv Therapeutics Inc.

VTVTvTv Therapeutics Inc.

NAS · US · Healthcare · Biotechnology · vtvtherapeutics.com

33.83USD-1.69%Mkt Cap: 132.58M USDP/E: —Last update: 2026-05-26

vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate i…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap132.58M USD

Enterprise Value342.44M USD

Revenue (TTM)36.84M USD

Gross Profit12.83M USD

Net Income (TTM)-26.97M USD

Revenue/Share3.729 USD

Last Price33.83 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees26

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-9.12

PEG—

EV/EBITDA-112.87

EV/Revenue9.30

P/S3.80

P/B6.84

EPS (TTM)-0.78

EPS (Forward)-3.89

52W Range

14.0066% of range44.00

52W High44.00 USD

52W Low14.00 USD

Profitability

Gross Margin34.83%

Oper. Margin63.15%

EBITDA Margin-8.24%

Profit Margin6.11%

ROE-41.86%

ROA-30.00%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-25.25M USD

CapEx (TTM)—

FCF Margin14.33%

FCF Yield3.98%

Net Debt-98.09M USD

Net Debt/EBITDA32.33

Balance Sheet

Debt/Equity0.00

Current Ratio14.36

Quick Ratio14.26

Book Value/Sh5.193 USD

Cash/Share7.904 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:40

Split DateNov 21, 2023

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)53.00 USD

Target Range44.00 USD – 67.00 USD

# Analysts6

Ownership

Shares Out.3.94M

Float2.40M

Insiders38.98%

Institutions38.35%

Short Interest

Short Ratio2.2d

Short % Float5.63%

Short % Out.3.48%

Shares Short136.96K

Short (prev mo.)82.24K

Technical

SMA 5035.71 (-5.3%)

SMA 20029.85 (+13.3%)

Beta0.26

S&P 52W Chg28.31%

Avg Vol (30d)53.20K

Avg Vol (10d)49.56K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—